It has been reported that AMPK activation is required in metformin-induced anti-tumor phenomena [9,22], while other studies showed that metformin exerts its action through AMPK-independent pathways [30] such as the mTOR, TGF-β pathway [23,31]. This evidence concerns the gene TGFB1 and neoplasm.